The process of discovery and development of a molecule is complex, long and costly. Before making a decision on the offer that best meets your needs, we offer online scientific resources and our latest news to help you get to know us better. Our experts are also at your disposal to help and support you in your research and development program.
Filter by category
- All
- Blog
- Congress
- Scientific resource
- Webinar
- Poster
- Scientific publication
- Press release
- Press coverage
- News
Filter by category
News
05/07/2023
Oncodesign Services receives global excellence awards
Oncodesign Services is thrilled to announce that we have been awarded 'Best Preclinical Services & Drug Discovery Company 2023 – France!
Blog
29/06/2023
Why you should consider tumor microenvironment for cancer therapy?
Combination of Tumor microenvironment and modulating therapeutic approaches may be required to overcome the resistance to treatments and prevent tumor recurrence.
Press release
27/06/2023
Oncodesign Services announce access to ImaginAb’s CD8 ImmunoPET technology
Oncodesign Services announces the execution of a Preclinical License and Supply Agreement with ImaginAb Inc.
Webinar
19/06/2023
[EN] Kinase Inhibitors for Inflammatory Diseases: Preclinical Development
Join the featured speakers for an informative webinar on unlocking the synergy in preclinical models and the importance of target validation for the personalized treatment of pancreatic cancer.
Blog
15/06/2023
How to mimic long COVID for drug discovery?
Long COVID is a complex multisystemic condition still poorly understood. Using optimal preclinical models is essential to understand their mechanisms better and develop new treatments.
News
22/05/2023
Oncodesign Services and Veritas In Silico enter into business cooperation
Oncodesign Services and Veritas In Silico Inc. announced that they have entered into a Memorandum of Understanding to respond to the needs of pharmaceutical companies seeking to develop innovative small molecule drugs targeting messenger RNA.
Blog
17/05/2023
Five Reasons why you should switch to digital PCR (dPCR)
Digital PCR has enhanced characteristics over qPCR across both its Protocols and Applications, including higher precision and sensitivity. Learn more here.
Webinar
17/05/2023
[EN] Preclinical Models for the Identification of Chemotherapy Predictive Signatures in Pancreatic Cancer
Join the featured speakers to learn how they utilized preclinical models such as primary cell cultures, patient-derived xenografts, and patient-derived organoids to develop unbiased predictive RNA-based signatures.
News
10/05/2023
Dr Eftychia Koumarianou joins as head of pharmaco-imaging and molecular radiotherapy
We announce the appointment of Dr Eftychia Koumarianou as head of its pharmaco-imaging and molecular radiotherapy (MRT) department.
Scientific resource
09/05/2023
Recent trends in drug discovery of covalent binders
Download the complete e-book on the role of boron and benzoxaboroles as reversible covalent binders to target the serine and threonine proteome.
Blog
09/05/2023
Covalent drugs and the potential of benzoxaboroles
Molecules based on boron and benzoxaboroles are exciting as reversible covalent binders to target the serine and threonine proteome.
Poster
09/05/2023
Generative AI Empowers the Search for PIM-1 Kinase Inhibitors: unveiling Novel Promising Chemical Entities
Discover this new poster co-written by Oncodesign Services and Iktos on the Generative AI Empowers the Search for PIM-1 Kinase Inhibitors.